Polar Capital Holdings Plc - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 175 filers reported holding XENON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
Polar Capital Holdings Plc ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$102,607,998
-11.8%
3,003,747
-0.6%
0.76%
+29.5%
Q2 2023$116,349,734
+7.8%
3,022,071
+0.2%
0.59%
-16.3%
Q1 2023$107,971,916
-10.1%
3,016,818
-1.0%
0.70%
-26.8%
Q4 2022$120,098,812
+24.9%
3,045,874
+14.4%
0.96%
+56.4%
Q3 2022$96,124,000
+24.4%
2,662,722
+4.8%
0.61%
+34.8%
Q2 2022$77,269,000
+15.4%
2,540,059
+16.0%
0.45%
+50.3%
Q1 2022$66,950,000
+27.0%
2,190,059
+29.7%
0.30%
+52.5%
Q4 2021$52,734,0001,688,0440.20%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders